Paul Zolkind, MD
Hometown: Sleepy Hollow, NY
Personal Statement: I chose WashU because of its extraordinary surgical training, research opportunities, and close knit community. My clinical interests are in head and neck cancer and endoscopic sinus and skull base surgery. My research is in combining genomics-based immunotherapies with advanced surgical techniques for patients with head and neck cancer. Outside the hospital, I love playing basketball, running with my dog, biking, and pretty much anything outdoors.
Undergraduate: Northwestern University, BA, 2009
Medical School: SUNY Downstate College of Medicine, 2013
Zolkind, Paul, Gavin P. Dunn, Tianxiang Lin, Malachi Griffith, Obi L. Griffith, and Ravindra Uppaluri. "Neoantigens in immunotherapy and personalized vaccines: Implications for head and neck squamous cell carcinoma." Oral Oncology (2016).
Uppaluri, Ravindra, Ashley Winkler, Tianxiang Lin, Jonathan Law, Bruce Haughey, Brian Nussenbaum, Randal Paniello, Jason Rich, Jason Diaz, Loren Michel, Tanya Wildes, Gavin Dunn, Dorina Kallogjeri, Paul Zolkind et al. "Biomarker and clinical response of oral cavity squamous cell carcinoma to the MEK 1/2 inhibitor trametinib: A phase II neoadjuvant window of opportunity clinical trial." Clinical Cancer Research (2016).
Zolkind, Paul, Lemuel Non, Rebecca Chernock, and Nsangou Ghogomu. "An Unusual Cause of Stridor in an 80-year-old Man." The American journal of medicine (2015).
Davitt, Katlin, Blake D. Babcock, Maly Fenelus, Chi Kong Poon, Abhishek Sarkar, Vincent Trivigno, Paul A. Zolkind et al. "The Anti-Cancer Peptide, PNC-27, Induces Tumor Cell Necrosis of a Poorly Differentiated Non-Solid Tissue Human Leukemia Cell Line that Depends on Expression of HDM-2 in the Plasma Membrane of these Cells." Annals of Clinical & Laboratory Science 44, no. 3 (2014): 241-248.